Inhibition of TRPM7 enhances TNF-related apoptosis inducing-ligand- (TRAIL-) induced apoptosis in PC-3 cells [12], indicating that TRPM7 contributes to the pathogenesis of prostate cancer and serves as a potential therapeutic target for prostate cancer [13]. The gene discussed is TRPM7; the disease is prostate carcinoma.